modulating the brain:facts,fiction,future · alain maertens de noordhout, liège bart nuttin,...
TRANSCRIPT
1
BBC Congress 2014 “MODULATING THE BRAIN: FACTS, FICTION, FUTURE” PHARMACOLOGICAL MODULATION ELECTRICAL MODULATION BEHAVIOURAL MODULATION COGNITION, MOVEMENT DISORDERS, EPILEPSY, HEADACHES, PAIN & PSYCHIATRIC
DISORDERS
4 October 2014
ICC Ghent
2
Patients Associations
(N= 17)
Clinical & Basic Neuroscience
Societies (N=19)
↓ ↓ ↓ ↓
Industrial Stakeholders
(N=11)
↘ ↘
↓ ↓
Belgian EDAB Rep. (N=1)
↘
↓ ↓
↙ ↙
Belgian Brain Council
↓↓ Board of
Directors (N=22)
(linguistic parity)
Organizing Committee Belgian Brain Congress 2014 Dirk VAN ROOST (Neurosurgery - chair) Wim FIAS (Neurosciences co-chair) Rebecca MÜLLER (Ups & Downs) Franco GIANNI (Together for the Brain) Steven LAUREYS (Neurology) Amelia LE ROY (Brain tumours)
Roland POCHET (Neurosciences - treasurer) Jean SCHOENEN (Neurology - coordinator) Bart STULENS (Medtronic) Charles VAN DER STRATEN (MS League) Paul VERBANCK (Psychiatry) Rufin VOGELS (Neurosciences)
Administrative Secretary Marina Van Oirschot [email protected] Tel: +32 3 322 28 50 - fax: +32 3 322 45 14
Congress Organizing Company A+A Communication bvba/sprl [email protected] Tel: +32 9 220 56 29 – Fax: +32 9 270 3 270
Belgian Brain Congress 2014
3
After Genval (2006), Ostend (2008), Brussels (2010) and Liège (2012), Ghent welcomes the 5th edition of the Belgian Brain Congress. By definition, the BBC congresses aim to be multidisciplinary even “transdisciplinary”, meaning they are evolving simultaneously between, through and beyond disciplines and focus on helping to understand the complexity of the brain and brain diseases.
During the last decade it has become evident that activity of brain areas and circuits can be modulated by a number of different so-called neuromodulatory methods ranging from electrical stimulation to drug treatment and behavioural therapies. Neuromodulation has opened novel perspectives to alleviate neurological and psychiatric symptoms in various brain disorders and dysfunctions. Neuromodulation has also raised much interest in the general population because it has the potential to modify function and performance of the normal human brain.
It seems timely therefore to present and discuss comprehensively the advantages and limitations of the different neuromodulation methods in brain disorders and to have an overview on present knowledge of the mechanisms of action of these methods. It is also a crucial societal issue to know whether neuromodulation methods should be recommended for cognitive enhancement and what the risks of such interventions are.
Novel therapeutic treatment of nervous system disorders represents one of the most significant and unmet needs in modern medicine. Deep-brain Stimulation (DBS) strategies have been shown to be remarkably effective for treating a number of neurological and psychiatric conditions including Parkinson’s Disease, dystonia, essential tremor, epilepsy, chronic pain, major depression, migraines, as well as a number of other conditions.
The BBC 2014 congress aims at providing this information to health providers, but also to patients and caregivers, in a transdisciplinary program spanning from the basic to the clinical neurosciences, and to medico-social matters.
The Ghent BBC 2014 Congress, as a participant of the “2014 Year of the Brain”, will be launched as a forum in which European researchers and clinicians will communicate and interact with a large panel of stakeholders including patients associations and policy makers interested in this innovative field.
Target audience:
• Health care professionals interested in neurological issues • Neuroscientists and students • Members of patients & family associations • Policy makers • Health journalists • Industrial stakeholders
4
Programme
09.00 – 10.00 Main Auditorium PLENARY SESSION 1 (chairpersons: R. Vogels, J. Schoenen)
ELECTRICAL NEUROMODULATION
09.00 – 09.30 Mechanisms of action of invasive neurostimulation
Nikos Logothetis, Tübingen
09.30 – 10.00 Mechanisms of action of non-invasive neurostimulation
Walter Paulus, Göttingen
10.00 – 11.00 Forum POSTER Session 1
Breakout room Van Eyck Satellite Symposium 1
Exhibitions, Coffee
Neurotransmitter imaging: a tool for detecting and monitoring brain modulation (General Electric)
11.00 – 12.40
Breakout room VanderGoes TOPICAL SESSION 1 (chairpersons: P. Santens, S. Henri)
Breakout room Van Eyck TOPICAL SESSION 2 (chairpersons: K. Audenaert, R. Müller)
11.00 – 11.20 Movement disorders Obsessive compulsive disorder
Alain Maertens de Noordhout, Liège Bart Nuttin, Leuven
11.20 – 11.40 Epilepsy Depression
Dirk Van Roost - Paul Boon, Ghent Chris Baeken, Ghent-Brussels
11.40 -12.00 Pain Consciousness disorders
Benoît Pirotte, Brussels Steven Laureys, Liège
12.00 – 12.20 Tinnitus Stroke
Dirk De Ridder, Antwerp Yves Vandermeeren, Mont-Godinne
12.20 – 12.40 Headache Addiction
Delphine Magis, Liège Jürgen Voges, Magdeburg
12.40 – 14.00
Forum POSTER Session 2 Exhibitions, Lunch
Breakout room Van Eyck Satellite Symposium 2
The Concept of Continuous Evidence based Neuromodulation (Medtronic SA/NV)
14.00 – 15.00 Main Auditorium
PLENARY SESSION 2 (chairpersons: W. Fias, J. De Keyser)
BEHAVIOURAL NEUROMODULATION
5
14.00 Critical appraisal of cognitive enhancement Nicole Wenderoth, Zürich
For last minute changes, please consult the website: http://www.belgianbraincouncil.be/congress2014/index.html
14.30 Mechanisms of action of behavioural modulation
Hubert Dinse, Bochum
15.00- 17.00
Forum Exhibitions, Coffee
Breakout room VanderGoes Breakout room Van Eyck
15.00 – 16.00 Satellite Symposium 3 OnabotulinumtoxinA as a biologic neuromodulator – motor effect ok, but a sensory effect? (Allergan)
15.00 – 16.30 Medico-Social Workshop Ethics, economics and quality of life in neuromodulation anno 2014-Year of the Brain. Chairpersons: Gianni Franco and Mary Baker, European Brain Council
16.30 – 18.00 Main Auditorium TOPICAL SESSION 3: (Chairpersons: A. Ivanoiu, G. Moonen)
16.30 – 16.50 Hypnosis
Marie-Elisabeth Faymonville, Liège
16.50 – 17.10 Cognitive revalidation
Steve Majerus, Liège
17.10 – 17.30 Neurofeedback
Bettina Sorger, Maastricht
17.30 – 17.50 Mindfulness
Rudi De Raedt, Ghent
17.50 – 18.20 PLENARY SESSION 3
Perspectives in neuromodulation
Optogenetics
Wim Vanduffel, Leuven-Boston
18.20 -18.30
Poster Prizes
18:30 – 19.30 Farewell cocktail & Musical Neuromodulation.
6
15.00 – 16.30 Medico-‐Social Workshop Ethics,economics and quality of life in neuromodulation anno 2014-‐Year of the Brain. CO-‐CHAIRS: Gianni Franco and Mary Baker, Past-‐President European Brain Council
Breakout room Van Eyck (co-‐chairpersons:A. Leroy, M. Mormal, Ch. van der Straten)
HOW CAN NEUROMODULATION
IMPROVE QUALITY OF LIFE? Bruno KASCHTEN, Belgian Society for Stereotactic and Functional Neurosurgery president, Neurosurgeon ULg, Frederic SUPIOT, Neurologist ULB.
SOCIO-‐ETHICAL, ECONOMICAL AND POLITICAL POINTS OF VIEW.
Ignaas Devisch (Philosopher, UGent) Dominique Jacquemin (Ethics, UCL) Jean Noel MISSA (Philosopher-‐ sociology, ULB) Jo Vandeurzen (Flemish Minister for Welfare, Public Health and Family) Monica De Coninck ( Federal Minister of Employment)
THE REALITY OF LIFE IN BELGIUM R. Deridder (Director General INAMI-‐RIZIV)
DEBATE with the assembly, only via questions from the floor (collected before the
meeting on paper sheets)
Satellite Symposium 1
General Electric Healthcare
Breakout room Van Eyck 10.00 – 11.00 Neurotransmitter imaging: a tool for detecting and monitoring brain
modulation
1) 10 years of Datscan® in Belgium Interactive session between a neurologist and a nuclear medicine physician on specific clinical cases.
Koen Van Laere (KUL), Michel Gonce (CHR Liège)
2) Early Diagnosis of Alzheimer’s disease, contribution of amyloid plaques imaging. Presentations of last development and data on Flutemetamol PET imaging.
Adrian Ivanoiu (UCL)
7
Satellite Symposium 2
Medtronic SA/NV
Breakout room Van Eyck 12:40 – 14.00 Deep brain stimulation at an earlier stage of Parkinson’s disease
CHAIR: Günther Deuschl (D)
1) Neurostimulation for PD with early motor complications: Michael Schüpbach (Bern,CH) 2) Early application of DBS, clinical and ethical aspects: Pierre Pollak (Genève,CH) 3) Stimulation of the STN at an early stage of Parkinson’s disease: Günther Deuschl (Kiel,D) Case-‐based presentations and interactive discussion with audience.
Satellite Symposium 3
Allergan SA/NV
Breakout room VanderGoes 15:00 – 16.00 “OnabotulinumtoxinA in the neurologist’s patients – not only motor effects,
but also sensory effects ?” CO-‐CHAIRS : Prof K.Paemeleire (UG) & Prof J.Schoenen(Ulg) Introduction: Chronic Migraine recommendations of the Belgian Headache Society Jean Schoenen (Ulg) 1) Science of onabotA’s neuromodulating mechanism of action: an accepted motor effect but a surprising sensory effect ? Oliver Dolly (Dublin,IRL) 2) OnabotA neuromodulation in clinical management of chronic migraine symptoms. Michel Vandenheede (CHC Liège) 3) OnabotA neuromodulation in clinical management of chronic post-‐stroke symptoms. Kristine Oostra (UZ Gent)
8
Posters & abstracts:
Free communications are very wellcome on any basic or clinical neuroscience topic. They will presented as posters. There will be poster discussions and a prize for the 3 best posters. Deadline for poster submission: July 1st, 2014 Maximum Poster size: 100 cm large x 120 cm high (portrait). Posters should be hung on the numbered poster boards between 8 :15 and 8 :45 hrs and visible the whole day. There are 2 dedicated poster discussion sessions from 10-‐11hrs and 12.40-‐14hrs. Each poster abstract should contain a short comment (max 150 words) on the significance of the research work presented in the abstract and the potential relevance for patient care. Abstracts to be submitted either in English, Dutch or French (one language). All accepted abstracts will be published and accessible via the Frontiers website (see http://www.frontiersin.org/events/Belgian_Brain_Council_2014MODULATING_THE_BRAIN_FACTS_FICTION_FUTURE/2177 The printed abstract book will contain:
• Abstracts of invited speakers (250 words) • Short comments in Dutch and French on the significance and the potential relevance for
patient care of the research work presented in each poster abstract
Poster Prizes A jury composed of Jacques De Keyser (VUB), Wim Fias (UGent), Rachelle Franzen (ULg), Rebecca Muller (Ups &Downs) and Jan Versijpt (VUB) will select during the congress the three best posters (quality of the discussion during poster viewing, innovation of the research/results, design of the poster). The 3 winners will be interviewed and video-‐recorded for podcasting. The recipients of the 3 Prizes (250 € each) will be announced at the closing ceremony. Only poster authors who are present at the closing ceremony will receive the Prize (presence mandatory). In case presenters of the best posters are absent, the 2nd best will receive the prize.
Webcasts
Webcasts will be produced during the congress. Invited speakers, selected poster presenters and representatives from the patients’ associations will be asked to briefly summarize their message and significance for understanding brain functions and managing its dysfunctions. These webcasts will be posted on the BBC website at http://www.belgianbraincouncil.be
Jean Schoenen & Rufin Vogels on behalf of the organizing committee.
9
Participants’ fee (to be completed on line: see: http://www.belgianbraincouncil.be/congressII/regist.php Category Until
Aug. 16
After Aug. 17
On site
A Academic & MD 125€ 150€ 175€
B Other health professionals
60€ 75€ 100€
C Industry 200€ 250€ 300€
D Resident & PhD below 30
0€ 0€ 25€
E Patient Associations member
0€ 0€ 25€
10
Practical information:
Date: 4 October 2014 Venue: ICC GHENT
Citadelpark B-9000 GHENT Tel. +32 (0)9 242 89 00 http://www.iccghent.com/typo/index.php
11
How to reach the ICC
BY CAR Coming from Kortrijk, Lille, Paris:
E17 direction Antwerp Take the Exit 'Gent -Centrum' (see below)
Coming from Brussels: E40 Brussels - Ostend Follow E17, direction Antwerp at the Zwijnaarde traffic junction Take the Exit 'Gent-Centrum' (see below)
Coming from Ostend, London E40 Ostend – Brussels Follow E17, direction Antwerp at the Zwijnaarde traffic junction Take the Exit 'Gent-Centrum' (see below)
At the exit Gent Centrum: Follow the Exit ‘Andere richtingen’ (You are now leaving the highway) Turn left at the traffic lights beneath the overpass You are now entering the St.-Lievenslaan Follow direction S.M.A.K. at the third traffic lights Drive along the S.M.A.K. museum (on your right hand side) 50 m further you will find the ICC International Convention Centre Ghent on your right hand side.
Using PUBLIC TRANSPORTATION (train) Coming from Lille, Paris:
Take a train to Brussels, change at Brussels Midi and take an IC train to Ostend or Knokke-Blankenberge. Ghent is the first stop (Gent-Sint-Pieters).
Coming from Ostend, London: Take an IC train to Brussels. Ghent is the second stop (Gent-Sint-Pieters) (first stop is Bruges).
On your arrival at the Gent-Sint-Pieters Railway Station you can either walk to the ICC (1.1 km = 15 minutes - to walk click here) or take bus 70 or 71 or 72 or 76 (bus station platforms 15 & 16) that all stop at the Ledeganckstraat directly opposite the entrance of the ICC. All of these as well as the lines 73 and 74 drive from the Ledeganckstraat to the Gent-Sint-Pieters Railway Station. www.belgianrail.be (train) www.delijn.be (bus)